M. Boers

发表

Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.

P Tugwell, P. Tugwell, C. Bombardier, 1993, The Journal of rheumatology.

Methodological issues in radiographic scoring methods in rheumatoid arthritis.

D. M. van der Heijde, M. Boers, D. Heijde, 1999, The Journal of rheumatology.

Interferon-γ Contributes to HLA-B27-associated Unfolded Protein Response in Spondyloarthropathies

R. Terkeltaub, C. Díaz-Torné, L. Harrold, 2013, The Journal of Rheumatology.

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

D. Felson, S. Kieszak, C. Goldsmith, 1993, Arthritis and rheumatism.

Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials.

S. van der Linden, D. M. van der Heijde, M. Boers, 1999, Rheumatology.

Smallest detectable difference in radiological progression.

M. Boers, A. Saudan, J. Edmonds, 1999, The Journal of rheumatology.

Robustness and generalizability of smallest detectable difference in radiological progression.

K. Bruynesteyn, M. Boers, A. Boonen, 2001, The Journal of rheumatology.

Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.

M. Boers, V. Strand, D. Heijde, 2001, The Journal of rheumatology.

How to interpret radiological progression in randomized clinical trials?

M. Boers, D. van der Heijde, R. Landewé, 2003, Rheumatology.